Dupont Capital Management Corp Reata Pharmaceuticals Inc Transaction History

Dupont Capital Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 24, 2020	SELL	$126.3 - $176.56 $254,115 - $355,238	-2,012 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$124.16 - $247.74 $34,268 - $68,376	276 Added 15.9%	2,012 $290,000
Q4 2019 Jan 27, 2020	SELL	$74.57 - $217.92 $133,182 - $389,205	-1,786 Reduced 50.71%	1,736 $355,000
Q3 2019 Oct 28, 2019	BUY	$71.26 - $95.75 $250,977 - $337,231	3,522 New	3,522 $283,000
Q2 2019 Jul 30, 2019	SELL	$77.72 - $94.35 $338,082 - $410,422	-4,350 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$51.9 - $101.79 $225,765 - $442,786	4,350 New	4,350 $372,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.